|
h1 Faculty of Health Sciences at the University of Cape Town | h1 Faculty of Health Sciences at the University of Cape Town |
| |
h2 ANAESTHESIA | h2 ANAESTHESIA |
* Cardiac anaesthesia | * Cardiac anaesthesia |
* Cardiac surgery | * Cardiac surgery |
* Liver transplants | * Liver transplants |
* Separation of conjoined twins | * Separation of conjoined twins |
* Burns unit | * Burns unit |
* Multi-discipline Paediatric Intensive Care Unit | * Multi-discipline Paediatric Intensive Care Unit |
| |
Supports following ICUs | Supports following ICUs |
* Respiratory intensive care unit | * Respiratory intensive care unit |
* Surgical intensive care unit | * Surgical intensive care unit |
| |
Centre for Pain Management | Centre for Pain Management |
* Patients with chronic pain | * Patients with chronic pain |
* Acute pain service available for postoperative patients | * Acute pain service available for postoperative patients |
| |
h2 CHILDHOOD AND ADOLESCENT HEALTH | h2 CHILDHOOD AND ADOLESCENT HEALTH |
* Full range of paediatric disciplines | * Full range of paediatric disciplines |
•Paediatric medicine | •Paediatric medicine |
•Paediatric surgery | •Paediatric surgery |
•Paediatric nursing | •Paediatric nursing |
•Paediatric pathology | •Paediatric pathology |
•Paediatric radiology | •Paediatric radiology |
•Paediatric anaesthetics | •Paediatric anaesthetics |
•Paediatric pulmonology | •Paediatric pulmonology |
| |
* Children’s public health | * Children’s public health |
* Pathology | * Pathology |
* Psychiatry in maternal and child health | * Psychiatry in maternal and child health |
* Child and adolescent psychiatry | * Child and adolescent psychiatry |
* Child health unit | * Child health unit |
* Critical care and children’s heart disease | * Critical care and children’s heart disease |
* Neonatology | * Neonatology |
| |
| Clinical Services: |
| * Ambulatory and emergency |
| * Allergy |
| * Community |
| * Dermatology |
| * Diabetes |
| * Endocrine |
| * Gastroentenology, heptatology and nutrition |
| * Haematology / oncology |
| * Infectious diseases and immunology |
| * Nuclear medicine |
| * Poisons |
| * Rheumatology |
| |
| h2 CLINICAL LABORATORY SCIENCES |
| |
| h3 A. ANATOMICAL PATHOLOGY |
| * Diseases common in SA: |
| • Tuberculosis |
| • Cardiomyopathy |
| • Foetal-alcohol syndrome |
| * Various cancers: |
| • Oesophageal |
| • Gastric |
| • Breast |
| • Cervical |
| • Colorectal and hepatocellular carcinomas |
| • Childhood cancers |
| * Renal and liver pathology |
| * Neonatal pathology |
| * Neuropathology |
| * Immunohistochemisty |
| * Electron microscopy |
| |
| h3 B. CHEMICAL PATHOLOGY |
| * Deals with metabolic disease |
| * Basic biochemistry |
| * Cell biology |
| * Molecular biology |
| |
| h3 C. FORENSIC MEDICINE AND TOXICOLOGY |
| * Violence against women and children |
| * Role of drugs and toxins in death |
| * Firearm injuries |
| |
| h3 D. HAEMATOLOGY |
| * Outpatient clinics |
| * Diagnostic and research laboratories |
| |
| |
| h3 E. HUMAN GENETICS |
| * Primary health care in community outreach clinics |
| * Highly sophisticated quaternary services |
| * Heritable disorders which cause childhood handicap incl: |
| • Blindness |
| • Crippling |
| • Profound deafness |
| • Mental retardation |
| * Clinical rotations in prenatal, paediatric and adult medical genetics incl exposure to: |
| • Dysmorphology |
| • Teratogenic disorders |
| • Metabolic disorders |
| • Neurogenetics |
| • Cardiogenetics |
| • Cancer genetics |
| * Theoretic and practical education in genetic counselling and communication |
| * Lab rotations in cytogenetics and molecular genetics |
| |
| h3 F. IMMUNOLOGY |
| * Immunology of infectious diseases |
| * Innate immunity and allergy |
| * Important advances in diseases e.g. |
| • Tuberculosis |
| • Bilharzia |
| • African Trypanosomiasis |
| • T-cell cykotine responses to allergens (immunotherapy) and mTB protein |
| • Clinical trials in UCT Lung Institute conducted in areas of: |
| o Antihistamines |
| o Asthma |
| o Eczema |
| |
| h3 G. MEDICAL BIOCHEMISTRY |
| * GnRH receptors, signalling, structure function and as target for development of therapeutics for treatment of reproductive cancers |
| * Role of cyclooxygenases and prostaglandins in cervical cancer and other uterine pathologies |
| * Identification of differentially regulated genes associated with the development of cervical cancer |
| * The role of the transcription factor AP-1 in oncogenesis |
| * Molecular mechanisms involved in the development and maintenance of oesophageal cancer |
| * Identification and characterisation of novel compounds that can be used in the treatment of cancer |
| * Angiotensin converting enzyme (ACE) Structure activity relationships and development of ACE inhibitors for treatment of hypertension, congestive heart failure, myocardial infarction and renal disease |
| * Application of functional proteomics for diagnostics, drug and vaccine development for infectious disease and cancers |
| |
| |
| h3 H. MEDICAL VIROLOGY |
| * referral laboratory for a large proportion of the regional virus identification |
| * members are part of national and international programmes to: |
| • discover an effective vaccine against HIV |
| • developed candidate HIV vaccines that have been tested in clinical trials |
| * participates in the WHO human papillomavirus laboratory network (Labnet) |
| * collaborating partner in the WHO African AIDS Vaccine Collaborative Centre in Biomedical Research |
| * interest in working on development of novel diagnostic tools for some of the more neglected but still clinically relevant viral diseases that are common in Africa |
| |
| h3 I. MEDICAL MICROBIOLOGY |
| * full range of microbiological diagnostic services including state-of-the-art molecular diagnostics |
| * involved in research activities: |
| • basic science |
| • clinical and diagnostic trials |
| * defining the epidemiology and strain biology of major infectious diseases in Southern Africa |
| * Important areas of research focus on: |
| • Tuberculosis |
| • Bacterial antibiotic resistance |
| • Nosocomial pathogens |
| • Outbreak surveillance |
| * developing and evaluating novel diagnostics which are applicable in low-resource settings |